跳至主要内容
临床试验/EUCTR2008-007162-32-IT
EUCTR2008-007162-32-IT进行中(未招募)不适用

ADVANCED MRI STUDY ON INFLAMMATORY AND DEGENRATIVE DAMAGE IN MULTIPLE SCLEROSIS - RMaIDSM

ISTITUTO C. MONDINO0 个研究点开始时间: 2008年11月6日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - relapsing-remitting Multiple Sclerosis patients elegible to treatment with Interferon beta 1-a (Avonex)i.m. or Glatiramer-acetate (copaxone) s.c
  • . age ≥ 18 years
  • . EDSS < 5.5
  • . ability to sign informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • . use of steroids and/or symptomatic drugs for fatigue within 30 days, other immunomodulatories within 3 months, immunosuppressant within 6 months
  • . cranial thrauma with sequelae
  • . concomitant partecipation to other clinical studies

研究者

发起方
ISTITUTO C. MONDINO

相似试验

ADVANCED MRI STUDY ON INFLAMMATORY AND DEGENRATIVE... | 临床试验